Family Medicine · Houston, TX
NPI
1659791572
Since 2014
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1200 Binz St Ste 1040
Houston, TX, 77004
Phone (713) 524-8700
Groups this clinician bills Medicare through
Medicare paid, 2024
$11K
206 services
Medicare patients, 2024
51
Average age 63
Drug cost, 2024
$3.8M
2,486 prescriptions
Company payments, 2025
$19K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Norris Tran Duc was code 99213 (office e&m - established), 55 times for 40 patients. In total Norris Tran Duc billed 206 services in 26 codes, and Medicare paid $11K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 55 | 40 | $45.34 | $2,493 |
| 99214 Office E&M - Established | Office | 44 | 27 | $68.83 | $3,029 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 21 | 21 | $129.83 | $2,726 |
By year: 2022 $11K for 244 services; 2023 $13K for 230 services; 2024 $11K for 206 services.
Medicare prescription drug claims, 2024
In 2024, the drug Norris Tran Duc prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 297 prescriptions and refills. In total Norris Tran Duc wrote 2,486 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 297 | 299 | 39 | $1.2M |
| Atorvastatin Calcium Generic | 193 | 341 | 40 | $1,073 |
| Tivicay Dolutegravir Sodium | 113 | 113 | 15 | $271K |
| Amlodipine Besylate Generic | 107 | 196 | 23 | $274 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 93 | 101 | 13 | $390K |
| Prezcobix Darunavir/Cobicistat | 90 | 99 | 11 | $241K |
| Metformin Hcl Generic | 70 | 118 | 17 | $174 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 68 | 82 | Under 11 | $359K |
| Juluca Dolutegravir/Rilpivirine | 62 | 74 | Under 11 | $249K |
| Lisinopril Generic | 61 | 111 | 13 | $296 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 60 | 68 | Under 11 | $245K |
| Alprazolam Generic | 46 | 47 | Under 11 | $252 |
| Rosuvastatin Calcium Generic | 40 | 73 | Under 11 | $236 |
| Losartan Potassium Generic | 38 | 66 | Under 11 | $268 |
| Ozempic Semaglutide | 31 | 32 | Under 11 | $28K |
Brand drugs: 1,098 claims; generic drugs: 1,388 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Norris Tran Duc $19K ($19K in general payments such as food, travel and fees) from 10 companies. The largest payer was ViiV Healthcare Company with $17K.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 43 | $17K |
| Gilead Sciences, Inc. GILD | 18 | $467 |
| Theratechnologies Inc. THTX | 6 | $204 |
| GlaxoSmithKline, LLC. GSK | 1 | $119 |
| Pfizer Inc. PFE | 4 | $98.33 |
| Merck Sharp & Dohme LLC MRK | 4 | $87.95 |
| EMD Serono, Inc. MRK.DE | 4 | $82.92 |
| Napo Pharmaceuticals Inc | 2 | $50.52 |
| Amgen Inc. AMGN | 2 | $38.87 |
| Exact Sciences Corporation EXAS | 1 | $18.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.